{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:59:56Z","timestamp":1793289596818,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00270-021-02874-6","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T13:02:47Z","timestamp":1622811767000},"page":"1561-1569","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["MRI-Derived Sarcopenia Associated with Increased Mortality Following Yttrium-90 Radioembolization of Hepatocellular Carcinoma"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7516-9255","authenticated-orcid":false,"given":"Phillip L.","family":"Guichet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bedros","family":"Taslakian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Aaltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Farquharson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cash J.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,4]]},"reference":[{"key":"2874_CR1","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S0140-6736(09)60381-0","volume":"373","author":"J Bruix","year":"2009","unstructured":"Bruix J, Llovet JM. Major achievements in hepatocellular carcinoma. Lancet. 2009;373:614\u20136.","journal-title":"Lancet"},{"key":"2874_CR2","doi-asserted-by":"crossref","unstructured":"Bruix J, Sherman M. American association for the study of liver diseases. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020\u20131022.","DOI":"10.1002\/hep.24199"},{"key":"2874_CR3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: european consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Aging. 2010;39:412\u201323.","journal-title":"Age Aging"},{"key":"2874_CR4","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","volume":"31","author":"L Martin","year":"2013","unstructured":"Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539\u201347.","journal-title":"J Clin Oncol"},{"key":"2874_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00535-014-0964-9","volume":"50","author":"S Iritani","year":"2015","unstructured":"Iritani S, Imai K, Takai K, et al. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma. J Gastroenterol. 2015;50:323\u201332.","journal-title":"J Gastroenterol"},{"key":"2874_CR6","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/MCG.0b013e318293a825","volume":"47","author":"J Meza-Junco","year":"2013","unstructured":"Meza-Junco J, Montano-Loza AJ, Baracos VE, et al. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. J Clin Gastroenterol. 2013;47:861\u201370.","journal-title":"J Clin Gastroenterol"},{"key":"2874_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.4143\/crt.2017.232","volume":"50","author":"Y Ha","year":"2018","unstructured":"Ha Y, Kim D, Han S, et al. Sarcopenia predicts prognosis in patients with newly diagnosed hepatocellular carcinoma independent of tumor stage and liver function. Cancer Res Treat. 2018;50:843\u201351.","journal-title":"Cancer Res Treat"},{"key":"2874_CR8","doi-asserted-by":"publisher","first-page":"9612","DOI":"10.3390\/ijms16059612","volume":"15","author":"K Imai","year":"2015","unstructured":"Imai K, Takai K, Hanai T, et al. Skeletal muscle depletion predicts the prognosis of patients with hepatocellular carcinoma treated with sorafenib. Int J Mol Sci. 2015;15:9612\u201324.","journal-title":"Int J Mol Sci"},{"key":"2874_CR9","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3389\/fonc.2019.01075","volume":"9","author":"J Lee","year":"2019","unstructured":"Lee J, Cho Y, Park S, et al. Skeletal muscle depletion predicts the prognosis of patients with hepatocellular carcinoma treated with radiotherapy. Front Oncol. 2019;9:1075.","journal-title":"Front Oncol"},{"key":"2874_CR10","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/bjs.9258","volume":"100","author":"N Harimoto","year":"2013","unstructured":"Harimoto N, Shirabe K, Yamashita YI, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg. 2013;100:1523\u201330.","journal-title":"Br J Surg"},{"key":"2874_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/jso.23976","volume":"112","author":"S Levolger","year":"2015","unstructured":"Levolger S, Van Vledder MG, Muslem R, et al. Sarcopenia impairs survival in patients with potentially curable hepatocellular carcinoma. J Surg Oncol. 2015;112:208\u201313.","journal-title":"J Surg Oncol"},{"key":"2874_CR12","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1111\/ajt.12221","volume":"13","author":"T Kaido","year":"2013","unstructured":"Kaido T, Ogawa K, Fujimoto Y, et al. Impact of sarcopenia on survival in patients undergoing living donor transplantation. Am J Transp. 2013;13:1549\u201356.","journal-title":"Am J Transp"},{"key":"2874_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jamcollsurg.2010.03.039","volume":"211","author":"MJ Englesbe","year":"2010","unstructured":"Englesbe MJ, Patel SP, He K, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg. 2010;211:271\u20138.","journal-title":"J Am Coll Surg"},{"key":"2874_CR14","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1007\/s11605-013-2348-5","volume":"17","author":"RM Dodson","year":"2013","unstructured":"Dodson RM, Firoozmand A, Hyder O, et al. Impact of sarcopenia on outcomes following intra-arterial therapy of hepatic malignancies. J Gastrointest Surg. 2013;17:2123\u201332.","journal-title":"J Gastrointest Surg"},{"key":"2874_CR15","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1186\/s12885-018-4673-2","volume":"18","author":"T Kobayashi","year":"2018","unstructured":"Kobayashi T, Kawai H, Nakano O, et al. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies. BMC Cancer. 2018;18:756.","journal-title":"BMC Cancer"},{"key":"2874_CR16","doi-asserted-by":"publisher","first-page":"e0232371","DOI":"10.1371\/journal.pone.0232371","volume":"15","author":"E Lanza","year":"2020","unstructured":"Lanza E, Masetti C, Messana G, et al. Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma. PLoS ONE. 2020;15:e0232371.","journal-title":"PLoS ONE"},{"key":"2874_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.108889","author":"A Faron","year":"2020","unstructured":"Faron A, Sprinkart AM, Pieper CC, et al. Yttrium-90 radioembolization for hepatocellular carcinoma: outcome prediction with MRI derived fat-free muscle area. Eur Radiol. 2020. https:\/\/doi.org\/10.1016\/j.ejrad.2020.108889.","journal-title":"Eur Radiol"},{"key":"2874_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1148\/radiol.14140690","volume":"275","author":"YJ Lee","year":"2015","unstructured":"Lee YJ, Lee JM, Lee JS, et al. Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging: a systematic review and meta-analysis. Radiology. 2015;275:97\u2013109.","journal-title":"Radiology"},{"key":"2874_CR19","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/hep.29602","volume":"67","author":"M Praktiknjo","year":"2018","unstructured":"Praktiknjo M, Book M, Luetkiens J, et al. Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis. Hepatology. 2018;67:1014\u201326.","journal-title":"Hepatology"},{"key":"2874_CR20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1139\/H10-067","volume":"35","author":"I Janssen","year":"2010","unstructured":"Janssen I. Evolution of sarcopenia research. Appl Physiol Nutr Metab. 2010;35:707\u201312.","journal-title":"Appl Physiol Nutr Metab"},{"key":"2874_CR21","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/gerona\/61.10.1059","volume":"61","author":"BH Goodpaster","year":"2006","unstructured":"Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci. 2006;61:1059\u201364.","journal-title":"J Gerontol A Biol Sci"},{"key":"2874_CR22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"KC Fearon","year":"2011","unstructured":"Fearon KC, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489\u201395.","journal-title":"Lancet Oncol"},{"key":"2874_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1056\/NEJMcibr1106880","volume":"365","author":"KC Fearon","year":"2011","unstructured":"Fearon KC. Cancer cachexia and fat-muscle physiology. N Engl J Med. 2011;365:565\u20137.","journal-title":"N Engl J Med"},{"key":"2874_CR24","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/hep.1840190508","volume":"19","author":"L Mondazzi","year":"1994","unstructured":"Mondazzi L, Botteli R, Brambilla G, et al. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology. 1994;19:1115\u201323.","journal-title":"Hepatology"},{"key":"2874_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/01.RVI.0000142602.79459.90","volume":"16","author":"JE Goin","year":"2005","unstructured":"Goin JE, Salem R, Carr BI, et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis. J Vasc Interv Radiol. 2005;16:195\u2013203.","journal-title":"J Vasc Interv Radiol"},{"key":"2874_CR26","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1148\/radiol.10091473","volume":"255","author":"RJ Lewandowski","year":"2010","unstructured":"Lewandowski RJ, Mulcahy MF, Kulik LM, et al. Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort. Radiology. 2010;255:955\u201365.","journal-title":"Radiology"},{"issue":"917","key":"2874_CR27","first-page":"923","volume":"22","author":"HT Hu","year":"2011","unstructured":"Hu HT, Kim JH, Lee LS, et al. Chemoembolization for hepatocellular carcinoma: a multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort. J Vasc Interv Radiol. 2011;22(917):923.","journal-title":"J Vasc Interv Radiol"},{"key":"2874_CR28","doi-asserted-by":"crossref","unstructured":"European association for the study of the liver; European organization for research and treatment of cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012; 56: 908\u2013943.","DOI":"10.1016\/j.jhep.2011.12.001"},{"key":"2874_CR29","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach: the ALBI grade. J Clin Oncol. 2015;33:550\u20138.","journal-title":"J Clin Oncol"},{"key":"2874_CR30","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jvir.2016.03.005","volume":"27","author":"R Hickey","year":"2016","unstructured":"Hickey R, Mouli S, Kulik L, et al. Independent analysis of albumin-bilirubin grade in a 765-patient cohort treated with transarterial locoregional therapy for hepatocellular carcinoma. J Vasc Interv Radiol. 2016;27:795\u2013802.","journal-title":"J Vasc Interv Radiol"},{"key":"2874_CR31","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/TP.0b013e31827a0f27","volume":"95","author":"RJ Cruz","year":"2013","unstructured":"Cruz RJ, Dew MA, Myaskovsky L, et al. Objective radiologic assessment of body composition in patients with end-stage liver disease: going beyond the BMI. Transplantation. 2013;95:617\u201322.","journal-title":"Transplantation"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-021-02874-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-021-02874-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-021-02874-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T17:05:36Z","timestamp":1632848736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-021-02874-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,4]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["2874"],"URL":"https:\/\/doi.org\/10.1007\/s00270-021-02874-6","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,4]]},"assertion":[{"value":"26 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Author Ryan Hickey is a consultant for and has received a speaking fee from Boston Scientific. The remaining authors have no financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required. This article does not contain any studies with animals performed by any of the authors. This single-center, retrospective cohort study was approved by the local Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This study has obtained IRB approval from the Institutional Review Board of New York University Grossman School of Medicine and the need for informed consent was waived.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"For this type of study consent for publication is not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}